Featuring an interview with Dr Omid Hamid, including the following topics:
- First-line treatment of metastatic melanoma (0:00)
- Triplet therapy for patients with BRAF-mutated metastatic melanoma (7:27)
- Case: A man in his mid 60s with previously untreated BRAF wild-type metastatic melanoma (15:44)
- Novel therapeutic strategies for patients with newly diagnosed melanoma (21:02)
- Immunotherapy strategies for second-line treatment of metastatic melanoma (29:25)
- Case: A man in his mid 40s with BRAF-mutated melanoma who experiences disease progression after treatment with ipilimumab and nivolumab (37:16)
CME information and select publications